Loss of WWOX contributes to cisplatin resistance in triple-negative breast cancer cells by modulating miR-182 and miR-214.

MLA

Batar, Bahadır, et al. “Loss of WWOX Contributes to Cisplatin Resistance in Triple-Negative Breast Cancer Cells by Modulating MiR-182 and MiR-214.” Turkish Journal of Medical Sciences, vol. 54, no. 5, Sept. 2024, pp. 1127–34. EBSCOhost, https://doi.org/10.55730/1300-0144.5891.

APA

Batar, B., Serdal, E., Erdal, B., & Oğul, H. (2024). Loss of WWOX contributes to cisplatin resistance in triple-negative breast cancer cells by modulating miR-182 and miR-214. Turkish Journal of Medical Sciences, 54(5), 1127–1134. https://doi.org/10.55730/1300-0144.5891

Chicago

Batar, Bahadır, Elif Serdal, Berna Erdal, and Hasan Oğul. 2024. “Loss of WWOX Contributes to Cisplatin Resistance in Triple-Negative Breast Cancer Cells by Modulating MiR-182 and MiR-214.” Turkish Journal of Medical Sciences 54 (5): 1127–34. doi:10.55730/1300-0144.5891.